|
Volumn 6, Issue 2, 2006, Pages 312-317
|
The sixth international conference on Cryptococcus and cryptococcosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
CHEMOKINE;
CPG OLIGODEOXYNUCLEOTIDE;
CYTOKINE;
FLUCONAZOLE;
FLUCYTOSINE;
GAMMA INTERFERON;
MELANIN;
RADIOISOTOPE;
VORICONAZOLE;
ANTIGENIC VARIATION;
ASTHMA;
CEREBROSPINAL FLUID;
CLINICAL TRIAL;
CONFERENCE PAPER;
CRYPTOCOCCOSIS;
CRYPTOCOCCUS;
CRYPTOCOCCUS NEOFORMANS;
CYTOTOXICITY;
DISEASE ASSOCIATION;
FUNGAL GENE;
FUNGAL STRAIN;
FUNGAL VIRULENCE;
HOST PATHOGEN INTERACTION;
HOST RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNIZATION;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
TH1 CELL;
TH2 CELL;
ANIMALS;
ANTIBODIES, FUNGAL;
ANTIFUNGAL AGENTS;
BRAIN;
CELL WALL;
CLINICAL TRIALS;
CRYPTOCOCCOSIS;
CRYPTOCOCCUS;
GENES, MATING TYPE, FUNGAL;
HUMANS;
IMMUNITY, CELLULAR;
MASSACHUSETTS;
POLYSACCHARIDES;
VIRULENCE;
FILOBASIDIELLA NEOFORMANS;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 33645091885
PISSN: 15671356
EISSN: 15671364
Source Type: Journal
DOI: 10.1111/j.1567-1364.2006.00068.x Document Type: Conference Paper |
Times cited : (5)
|
References (0)
|